Statistics for MeVis Medical Solutions AG (id:2883 M3V)

Valuation metrics

Market cap

45.14M

Enterprise value

39.90M

Trailing P/E (ttm)

7.85

Forward P/E

PEG ratio

-0.21

Price/Sales (ttm)

2.56

Price/Book (mrq)

2.53

Enterprise Value/Revenue

2.26

Enterprise Value/EBITDA

8.27

Overview

Shares outstanding

1.82M

Float

479.39K

Shares short

% Held by insiders

0.74%

% Held by institutions

0.21%

Average volume (10 days)

51.00

Average volume (90 days)

Price summary

52-Week low

22.80

52-Week high

27.40

52-Week change

-1.61%

Beta

0.00

50-Day moving average

23.89

200-Day moving average

25.05

Dividends and splits

Forward annual dividend rate

3.80

Forward annual dividend yield

0.15

Trailing annual dividend rate

0.95%

Trailing annual dividend yield

0.04

5-Year annual dividend yield

Payout ratio

0.30

Dividend date

Ex-dividend date

March 20th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

September 30th, 2023

Most recent quarter (mrq)

March 31th, 2024

Profitability

Profit margin

32.60%

Operating margin

26.25%

Operational effectiveness

Return on assets

11.94%

Return on equity

32.27%

Income statement

Revenue (ttm)

9.70

Revenue per share (ttm)

9.70

Quarterly revenue growth (yoy)

0.46

Gross profit (ttm)

16.90M

EBITDA

5.17M

Net income to common (ttm)

5.75M

Diluted EPS (ttm)

3.16

Quarterly earnings growth (yoy)

45.50%

Balance sheet

Total cash (mrq)

4.87M

Total cash per share (mrq)

2.68

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

456.90%

Book value per share (mrq)

9.80

Cash flow

Cash flow statement

6.04M

Levered free cash flow (LFCF)

4.92M